Skip to main content

Table 1 Baseline characteristics

From: Transplant outcomes in positive complement-dependent cytotoxicity- versus flow cytometry-crossmatch kidney transplant recipients after successful desensitization: a retrospective study

Variables

CDC − FCM−

(n = 274)

CDC − FCM+

(n = 39)

CDC + FC+

(n = 17)

P

Age, years

48 (36–55)

52 (45–57)

46 (41–56)

0.059

Sex, males

178 (65.0%)

6 (15.4%)

4 (2.1%)

< 0.001

Donor age, years

45 (34–52)

43 (33–53)

41 (29–49)

0.647

Donor sex, males

111 (40.5%)

24 (61.5%)

5 (29.4%)

0.004

Dialysis duration

   

0.228

 Preemptive

95 (34.7%)

11 (28.2%)

4 (23.5%)

 

 ≤ 1 year

118 (43.1%)

13 (33.3%)

8 (47.1%)

 

 >  1 year

61 (22.3%)

15 (38.5%)

5 (29.4%)

 

Retransplantation

12 (4.4%)

6 (15.4%)

5 (29.4%)

< 0.001

Pretransplant DM

73 (26.0%)

13 (33.3%)

2 (11.8%)

0.245

Pretransplant CVD

20 (7.3%)

3 (7.7%)

1 (5.9%)

0.971

  1. CDC Complement dependent cytotoxicity, FC Flow cytometry